{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:58:20Z","timestamp":1791849500173,"version":"4.3.4"},"reference-count":88,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T00:00:00Z","timestamp":1621728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The musculoskeletal (MSK) manifestations in the kidney transplant recipient (KTxR) could lead to decreased quality of life and increased morbidity and mortality. However, the prevalence of these MSK manifestations is still not well-recognized. This review aimed to investigate the prevalence and outcomes of MSK manifestations in KTxR in the last two decades. Materials and Methods: Research was performed in EBSCO, EMBASE, CINAHL, PubMed\/MEDLINE, Cochrane, Google Scholar, PsycINFO, Scopus, Science Direct, and Web of Science electronic databases were searched during the years 2000\u20132020. Results: The PRISMA flow diagram revealed the search procedure and that 502 articles were retrieved from the initial search and a total of 26 articles were included for the final report in this review. Twelve studies reported bone loss, seven studies reported a bone pain syndrome (BPS) or cyclosporine-induced pain syndrome (CIPS), and seven studies reported hyperuricemia (HU) and gout. The prevalence of MSK manifestations in this review reported as follow: BPS\/CIPS ranged from 0.82% to 20.7%, while bone loss ranged from 14% to 88%, and the prevalence of gout reported in three studies as 7.6%, 8.0%, and 22.37%, while HU ranged from 38% to 44.2%. Conclusions: The post-transplantation period is associated with profound MSK abnormalities of mineral metabolism and bone loss mainly caused by corticosteroid therapy, which confer an increased fracture risk. Cyclosporine (CyA) and tacrolimus were responsible for CIPS, while HU or gout was attributable to CyA. Late diagnosis or treatment of post-transplant bone disease is associated with lower quality of life among recipients<\/jats:p>","DOI":"10.3390\/medicina57060525","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:01:20Z","timestamp":1621814480000},"page":"525","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence of Musculoskeletal Manifestations in Adult Kidney Transplant\u2019s Recipients: A Systematic Review"],"prefix":"10.3390","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1992-3740","authenticated-orcid":false,"given":"Adla B.","family":"Hassan","sequence":"first","affiliation":[{"name":"College of Medicine and Medical Sciences, Arabian Gulf University (AGU), 323 Manama, Bahrain"},{"name":"Department of Internal Medicine, University Medical Center (UMC), King Abdullah Medical City (KAMC), 323 Manama, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanz W.","family":"Ghalib","sequence":"additional","affiliation":[{"name":"College of Medicine and Medical Sciences, Arabian Gulf University (AGU), 323 Manama, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8990-1320","authenticated-orcid":false,"given":"Haitham A.","family":"Jahrami","sequence":"additional","affiliation":[{"name":"College of Medicine and Medical Sciences, Arabian Gulf University (AGU), 323 Manama, Bahrain"},{"name":"Ministry of Health, 410 Manama, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amgad E.","family":"El-Agroudy","sequence":"additional","affiliation":[{"name":"College of Medicine and Medical Sciences, Arabian Gulf University (AGU), 323 Manama, Bahrain"},{"name":"Department of Internal Medicine, University Medical Center (UMC), King Abdullah Medical City (KAMC), 323 Manama, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(96)90138-9","article-title":"Long-term bone loss in kidney transplant recipients: A cross-sectional and longitudinal study","volume":"28","author":"Pichette","year":"1996","journal-title":"Am. J. Kidney Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00296-002-0283-y","article-title":"Joint pain and arthritis in renal transplant recipients and correlation with cyclosporine therapy","volume":"23","author":"Yucel","year":"2003","journal-title":"Rheumatol. Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0041-1345(98)02031-4","article-title":"The incidence and management of osteoporosis, gout, and avascular necrosis in recipients of renal allografts functioning more than 20 years (level 5A) treated with prednisone and azathioprine","volume":"31","author":"Braun","year":"1999","journal-title":"Transpl. Proc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semnephrol.2004.09.008","article-title":"Uric acid and transplantation","volume":"25","author":"Mazzali","year":"2005","journal-title":"Semin. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1093\/ndt\/12.11.2389","article-title":"Colchicine myopathy in renal transplant recipients on cyclosporin","volume":"12","author":"Ducloux","year":"1997","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ki.1993.218","article-title":"Epiphyseal impaction as a cause of severe osteoarticular pain of lower limbs after renal transplantation","volume":"44","author":"Goffin","year":"1993","journal-title":"Kidney Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1432-2277.2001.tb00004.x","article-title":"Calcineurin-inhibitor induced pain syndrome (CIPS): A severe disabling complication after organ transplantation","volume":"14","author":"Grotz","year":"2001","journal-title":"Transpl Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/qjmed\/90.5.359","article-title":"Acute bone-marrow oedema in cyclosporin-treated renal transplant recipients","volume":"90","author":"Jagose","year":"1997","journal-title":"QJM"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0272-6386(12)70118-X","article-title":"Musculoskeletal complications after renal transplantation: Pathogenesis and treatment","volume":"19","author":"Julian","year":"1992","journal-title":"Am. J. Kidney Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1016\/S0041-1345(98)00920-8","article-title":"Relationship between steroid dosage and osteonecrosis of the femoral head after renal transplantation as measured by magnetic resonance imaging","volume":"30","author":"Kubo","year":"1998","journal-title":"Transplant Proc."},{"key":"ref_11","first-page":"131","article-title":"Bone loss in pediatric renal transplant recipients","volume":"23","author":"Sobh","year":"2003","journal-title":"Nefrologia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/B:UROL.0000032694.80134.5f","article-title":"Bone mineral density in live related kidney transplant children and adolescents","volume":"36","author":"Wafa","year":"2004","journal-title":"Int. Urol. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clinimag.2018.10.022","article-title":"Calcineurin-inhibitor induced pain syndrome-Magnetic resonance imaging and scintigraphic findings illustrated through two cases","volume":"53","author":"Chadha","year":"2019","journal-title":"Clin. Imaging"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM199111143252016","article-title":"Musculoskeletal pain in renal-transplant recipients","volume":"325","author":"Lucas","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_15","first-page":"653","article-title":"Leg bone pain syndrome due to cyclosporine in a renal transplant patient","volume":"12","year":"1994","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1097\/00007890-199605150-00031","article-title":"Distal lower limb bone pain after renal transplantation","volume":"61","author":"Goffin","year":"1996","journal-title":"Transplantation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5414\/CNP59098","article-title":"Post-renal transplant syndrome of transient lower limb joint pain: Description under a tacrolimus-based immunosuppression","volume":"59","author":"Goffin","year":"2003","journal-title":"Clin. Nephrol."},{"key":"ref_18","first-page":"210","article-title":"Reflex sympathetic dystrophy syndrome of the lower limbs in a renal transplant patient treated with tacrolimus","volume":"70","author":"Puig","year":"2000","journal-title":"Transplantation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1210\/jc.2009-0205","article-title":"Approach to the patient with transplantation-related bone loss","volume":"94","author":"Ebeling","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5414\/CNCS108875","article-title":"Costimulation pathway blockade in kidney transplant recipients with de-novo rheumatoid arthritis","volume":"5","author":"Sheta","year":"2017","journal-title":"Clin. Nephrol. Case Stud."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/nep.12190","article-title":"Acute polyarthritis immediately after kidney transplantation: A medication-induced rheumatoid arthritis flare?","volume":"19","author":"Brumby","year":"2014","journal-title":"Nephrology (Carlton)"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1681\/ASN.V115974","article-title":"Renal transplant-associated hyperuricemia and gout","volume":"11","author":"Clive","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/ndt\/gft378","article-title":"Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis","volume":"29","author":"Bose","year":"2014","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11926-012-0235-9","article-title":"Gout and organ transplantation","volume":"14","author":"Stamp","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5527\/wjn.v4.i3.324","article-title":"Asymptomatic hyperuricemia following renal transplantation","volume":"4","author":"Bellomo","year":"2015","journal-title":"World J. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1600-6143.2011.03872.x","article-title":"Reduced fracture risk with early corticosteroid withdrawal after kidney transplant","volume":"12","author":"Nikkel","year":"2012","journal-title":"Am. J. Transplant."},{"key":"ref_27","first-page":"420","article-title":"Comparison of alendronate and pamidronate on bone loss in kidney transplant patients for the first 6 months of transplantation","volume":"5","author":"Omidvar","year":"2011","journal-title":"Iran J. Kidney Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/1744-9987.12018","article-title":"Clinicopathological analysis of persistent hypercalcemia and hyperparathyroidism after kidney transplantation in long-term dialysis patients","volume":"17","author":"Nakamura","year":"2013","journal-title":"Ther. Apher. Dial."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5500\/wjt.v5.i4.231","article-title":"Mineral and bone disorder after kidney transplantation","volume":"5","author":"Taweesedt","year":"2015","journal-title":"World J. Transpl."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2013080851","article-title":"Kidney transplantation with early corticosteroid withdrawal: Paradoxical effects at the central and peripheral skeleton","volume":"25","author":"Iyer","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1034\/j.1600-6143.2002.20512.x","article-title":"Transient bone marrow edema in renal transplantation: A distinct post-transplantation syndrome with a characteristic MRI appearance","volume":"2","author":"Coates","year":"2002","journal-title":"Am. J. Transpl."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1297-319X(03)00095-2","article-title":"Tacrolimus pain syndrome in renal transplant patients: Report of two cases","volume":"71","author":"Franco","year":"2004","journal-title":"Jt. Bone Spine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.ki.5001833","article-title":"Calcineurin-inhibitor induced pain syndrome after organ transplantation","volume":"70","author":"Collini","year":"2006","journal-title":"Kidney Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1432-2277.2008.00668.x","article-title":"Post-transplant distal limb syndrome: Clinical diagnosis and long-term outcome in 37 renal transplant recipients","volume":"21","author":"Tillmann","year":"2008","journal-title":"Transpl. Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.tp.0000188722.84775.af","article-title":"New-onset gout after kidney transplantation: Incidence, risk factors and implications","volume":"80","author":"Abbott","year":"2005","journal-title":"Transplantation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/TP.0b013e318254391b","article-title":"Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival","volume":"94","author":"Numakura","year":"2012","journal-title":"Transplantation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.transproceed.2012.07.033","article-title":"Hyperuricemia in adult renal allograft recipients: Prevalence and predictors","volume":"44","author":"Malheiro","year":"2012","journal-title":"Transpl. Proc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.transproceed.2013.09.038","article-title":"Uric acid is highly associated with kidney allograft survival in a time-varying analysis","volume":"46","author":"Weng","year":"2014","journal-title":"Transpl. Proc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/RHU.0000000000000140","article-title":"A pilot study on dual-energy computed tomography for detection of urate deposits in renal transplant patients with asymptomatic hyperuricemia","volume":"20","author":"Nicolaou","year":"2014","journal-title":"J. Clin. Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.transproceed.2019.04.050","article-title":"Gout Severity in Recipients of Kidney Transplant","volume":"51","author":"Brigham","year":"2019","journal-title":"Transpl. Proc."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Folkmane, I., Tzivian, L., Folkmane, E., Valdmane, E., Kuzema, V., and Petersons, A. (2020). Predictors of Hyperuricemia after Kidney Transplantation: Association with Graft Function. Medicina, 56.","DOI":"10.3390\/medicina56030095"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.V1161093","article-title":"High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation","volume":"11","author":"Mawad","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1097\/00007890-200012270-00011","article-title":"Posttransplant bone disease: Evidence for a high bone resorption state","volume":"70","author":"Cayco","year":"2000","journal-title":"Transplantation"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/ndt\/17.7.1318","article-title":"Changes in bone mineral density over 18 months following kidney transplantation: The respective roles of prednisone and parathyroid hormone","volume":"17","author":"Casez","year":"2002","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00007890-200202270-00024","article-title":"Effect of kidney transplantation on bone mass and body composition in males","volume":"73","author":"Ulivieri","year":"2002","journal-title":"Transplantation"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0041-1345(03)00737-1","article-title":"Osteoarticular pain and bone mineral density in renal transplantation","volume":"35","author":"Toro","year":"2003","journal-title":"Transpl. Proc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00776-003-0716-9","article-title":"Risk factors for nontraumatic osteonecrosis of the femoral head after renal transplantation","volume":"8","author":"Inoue","year":"2003","journal-title":"J. Orthop. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1097\/01.ASN.0000093255.56474.B4","article-title":"Preventing bone loss in renal transplant recipients with vitamin D","volume":"14","author":"Ghoneim","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2214\/AJR.05.1097","article-title":"Hip pain in renal transplant recipients: Symptomatic gluteus minimus and gluteus medius tendon abnormality as an alternative MRI diagnosis to avascular necrosis","volume":"188","author":"Demant","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00296-008-0585-9","article-title":"Musculoskeletal affections among kidney recipients: Prevalence and risk predictors","volume":"28","author":"Atallah","year":"2008","journal-title":"Rheumatol. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1744-9987.2011.00932.x","article-title":"Natural history of mineral and bone disorders after living-donor kidney transplantation: A one-year prospective observational study","volume":"15","author":"Kawarazaki","year":"2011","journal-title":"Ther. Apher. Dial."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7126290","DOI":"10.1155\/2016\/7126290","article-title":"Prevalence of Hypercalcaemia in a Renal Transplant Population: A Single Centre Study","volume":"2016","author":"Amin","year":"2016","journal-title":"Int. J. Nephrol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1440-1797.2006.00708.x","article-title":"From marrow oedema to osteonecrosis: Common paths in the development of post-transplant bone pain","volume":"11","author":"Elder","year":"2006","journal-title":"Nephrology (Carlton)"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ndtplus\/sfr156","article-title":"Pain syndrome with stress fractures in transplanted patients treated with calcineurin inhibitors","volume":"5","author":"Gurin","year":"2012","journal-title":"Clin. Kidney J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00007890-198702000-00007","article-title":"Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years","volume":"43","author":"Kahan","year":"1987","journal-title":"Transplantation"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0272-6386(87)80103-8","article-title":"The incidence of gout in renal transplant recipients","volume":"10","author":"West","year":"1987","journal-title":"Am. J. Kidney Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9610(88)80196-X","article-title":"Hyperuricemia after renal transplantation","volume":"156","author":"Gores","year":"1988","journal-title":"Am. J. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM198908033210504","article-title":"Cyclosporine-induced hyperuricemia and gout","volume":"321","author":"Lin","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"ref_59","first-page":"1391","article-title":"Cyclosporine-induced hyperuricemia after renal transplant: Clinical characteristics and mechanisms","volume":"24","author":"Ahn","year":"1992","journal-title":"Transpl. Proc."},{"key":"ref_60","first-page":"1773","article-title":"Hyperuricemia and gout in renal allograft recipients","volume":"24","author":"Delaney","year":"1992","journal-title":"Transpl. Proc."},{"key":"ref_61","first-page":"2722","article-title":"Cyclosporine-induced hyperuricemia and gout in renal transplants","volume":"27","author":"Hachicha","year":"1995","journal-title":"Transpl. Proc."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/01.TP.0000128357.49077.19","article-title":"Reduced incidence of hyperuricemia, gout, and renal failure following liver transplantation in comparison to heart transplantation: A long-term follow-up study","volume":"77","author":"Shibolet","year":"2004","journal-title":"Transplantation"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1432-2277.2001.tb00075.x","article-title":"Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients","volume":"14","author":"Boots","year":"2001","journal-title":"Transpl. Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2796.1990.tb00195.x","article-title":"Azathioprine and allopurinol: A potentially dangerous combination","volume":"228","author":"Sharman","year":"1990","journal-title":"J. Int. Med."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Dalbeth, N., House, M.E., Horne, A., and Taylor, W.J. (2013). Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with gout. BMC Musculoskelet. Disord., 14.","DOI":"10.1186\/1471-2474-14-363"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00002281-200307000-00013","article-title":"Mechanisms of glucocorticoid-induced osteoporosis","volume":"15","author":"Canalis","year":"2003","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.5650090102","article-title":"Changes in bone mass early after kidney transplantation","volume":"9","author":"Horber","year":"1994","journal-title":"J. Bone Miner. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MNH.0b013e3283546ee0","article-title":"Management of mineral and bone disorder after kidney transplantation","volume":"21","author":"Molnar","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: Pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos. Int."},{"key":"ref_70","first-page":"1764","article-title":"Fracture frequency after kidney transplantation","volume":"26","author":"Nisbeth","year":"1994","journal-title":"Transpl. Proc."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1016\/S0041-1345(01)02580-5","article-title":"Immunosuppression and bone loss after transplantation","volume":"33","author":"Torregrosa","year":"2001","journal-title":"Transpl. Proc."},{"key":"ref_72","first-page":"2224","article-title":"Factors involved in the loss of bone mineral density after renal transplantation","volume":"27","author":"Torregrosa","year":"1995","journal-title":"Transpl. Proc."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1034\/j.1399-3046.2000.00106.x","article-title":"Risk factors for bone mineral density loss in pediatric renal transplant patients","volume":"4","author":"Ellis","year":"2000","journal-title":"Pediatr. Transpl."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00467-008-0779-0","article-title":"Factors related to long-term renal transplant function in children","volume":"23","author":"Ellis","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00007890-199702150-00009","article-title":"Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: A prospective study","volume":"63","author":"Aroldi","year":"1997","journal-title":"Transplantation"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.kint.2016.10.008","article-title":"Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation","volume":"91","author":"Evenepoel","year":"2017","journal-title":"Kidney Int."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/j.1600-6143.2006.01557.x","article-title":"Late low-dose steroid withdrawal in renal transplant recipients increases bone formation and bone mineral density","volume":"6","author":"Farmer","year":"2006","journal-title":"Am. J. Transpl."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1749-6632.2002.tb04204.x","article-title":"Mechanisms of glucocorticoid action in bone","volume":"966","author":"Canalis","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1523-1755.2005.00306.x","article-title":"A prospective randomized study for prevention of postrenal transplantation bone loss","volume":"67","author":"Mohsen","year":"2005","journal-title":"Kidney Int."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/nep.13028","article-title":"Management of mineral and bone disorders in renal transplant recipients","volume":"22","author":"Damasiewicz","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/TP.0000000000000823","article-title":"A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation","volume":"100","author":"Wolf","year":"2016","journal-title":"Transplantation"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1093\/ndt\/gfq777","article-title":"The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: A 1-year prospective observational study","volume":"26","author":"Kawarazaki","year":"2011","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ekir.2017.08.016","article-title":"Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients","volume":"3","author":"Cruzado","year":"2018","journal-title":"Kidney Int. Rep."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/ajt.12425","article-title":"Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation","volume":"13","author":"Perrin","year":"2013","journal-title":"Am. J. Transpl."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0041-1345(99)00995-1","article-title":"Improvement of parathyroid function after kidney transplantation: Effect on parathyroid functional mass","volume":"32","author":"Bonarek","year":"2000","journal-title":"Transpl. Proc."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e13988","DOI":"10.1111\/ctr.13988","article-title":"Long-term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism","volume":"34","author":"Moreno","year":"2020","journal-title":"Clin. Transpl."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2215\/CJN.03920808","article-title":"Calcium metabolism in the early posttransplantation period","volume":"4","author":"Evenepoel","year":"2009","journal-title":"Clin. J. Am.Soc. Nephrol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.5301\/JN.2011.7767","article-title":"Recent insights into vitamin D and its receptor","volume":"24","author":"Messa","year":"2011","journal-title":"J. Nephrol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/6\/525\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:06:26Z","timestamp":1760162786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/6\/525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,23]]},"references-count":88,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["medicina57060525"],"URL":"https:\/\/doi.org\/10.3390\/medicina57060525","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,23]]}}}